P-Chirogenic Benzo-Fused Phenoxaphosphane
(1 equiv.) was added and the solution was stirred for an additional
2h at room temp. The solvent and all the volatiles were removed in
vacuo and the product obtained was dissolved again in toluene
(1 mL) and filtered through a short silica column (eluent: toluene).
The evaporation of the volatiles yields the product as a white oil
(138 mg, 0.29 mmol, 86%). 31P NMR (CDCl3): δ = –66.36, –65.54
ppm. (HRMS, FAB+): m/z calcd. for C29H31O4P: 474.319; found:
475.200 [M + H]+.
MeN), 3.70 (m, 1 H, H17), 6.30 (dd, 1 H, H10), 6.53 (dd, 1 H, H12),
6.83 (t, 3J = 7.2 Hz, 1 H, H21), 7.02 (t, 3J = 7.5 Hz, 1 H, H20), 7.10
3
(d, J = 8.4 Hz, 1 H, H19), 7.10–7.30 (m, 3 H), 7.3 (m, 1 H, Phm),
7.35 (m, 1 H, Phi), 7.40 (m, 1 H, H6), 7.52 (t, 3J = 7.5 Hz, 1 H,
H5), 7.66 (m, 2 H, Pho), 7.80 (m, 1 H, H3) ppm. [α]2D5 = –33.9 (c =
0.24, CHCl ). IR (KBr): ν
= 1588 (s), 1535 (m), 1452 (s), 1429
˜
3
max
(m), 1312 (m), 1218 cm–1 (m). (HRMS, FAB+): m/z calcd. for
C28H26NO2PPd: 545.07; found: 545.07.
Compound 8: Experimental procedure as reported for 7; yield 63%.
31P NMR (121.5 MHz, CDCl3): δ = –5.40 ppm. 1H NMR
(300.1 MHz, CDCl3): δ = 1.80 (m, 6 H), 2.8–3.1 (m, 12 H), 4.30–
4.60 (m, 2 H), 6.20–6.50 (m, 2 H), 6.60–6.80 (m, 3 H), 7.00–8.20
(m, 29 H) ppm. (HRMS, FAB+): m/z calcd. for C32H28NO2PPd:
595.09; found 595.09.
Compound 7: To a solution of 3 (25 mg, 0.086 mmol) in dichloro-
methane (5 mL) was added triethylamine (1.1 equiv.) and the solu-
tion was stirred for 30 min. At this point (S)-5 (25 mg, 0.043 mmol)
was added and the solution was stirred for an additional hour. The
solution was filtered through a short pad of silica (eluent: CH2Cl2),
next the solvent was evaporated off to give rise to the dia-
stereomeric mixture of compounds 7a,b as a yellow solid (36 mg,
0.066 mmol, 72%). Subsequently the diastereoisomers were sepa-
rated by radial chromatography (eluent: CH2Cl2/hexane = 20:1).
31P NMR (CDCl3): δ = –5.76, –4.97 ppm. (HRMS, FAB+):
m/z calcd. for C28H26NO2PPd: 545.070; found: 545.070.
C28H26NO2PPd (545.07): calcd. C 61.60, H 4.80; found C 61.55, H
4.76.
Compounds 9a,b: Compound 4a,b (498 mg, 0.975 mmol) and (S)-6
(333 mg, 0.427 mmol) were placed in a Shlenk tube and sub-
sequently solubilized in dichloromethane (20 mL).The resultant
solution was allowed to stir for 30 min. Next, the solvent was evap-
orated to give rise to the diastereomeric mixture of compounds
9a,b as a yellow solid. Subsequently the diastereoisomers were sep-
arated by chromatography (eluent: CH2Cl2). 31P NMR: δ = –8.20,
–12.70 ppm.
Compound (RP)-7a: First diastereoisomer eluted (21 mg, 84%). 31
P
NMR (121.5 MHz, CDCl3):
δ
=
–5.76 ppm. 13C NMR
Compounds (SP)-9a: First diastereoisomer eluted (300 mg, 86%).
31P NMR (121.5 MHz, CDCl3): δ = –12.72 ppm. 13C NMR
(75.4 MHz, CDCl3): δ = 15.89, 21.17, 22.27, 22.90–22.96, 25.71,
31.58, 31.83, 34.14, 41.18, 47.44, 48.50, 51.5, 73.67, 79.83, 107.08,
107.76, 110.20, 110.85, 114.70, 117.40–117.45, 117.75, 123.54,
124.01, 124.64–124.73, 124.73–125.00, 125.65, 128.11, 128.25,
128.83, 130.50, 131.23, 132.34, 133.12, 133.40, 133.60, 134.11,
134.59, 134.75, 137.00, 137.23, 148.78–148.81, 151.53, 151.90,
151.95, 153.53, 154.36 ppm. 1H NMR (300.1 MHz, CDCl3): δ =
0.65 (d, 3J = 6.6 Hz, 3 H), 0.80–2.00 (m, 15 H), 2.16 (d, J = 6.6 Hz,
(125.7 MHz, CDCl3): δ = 10.59, 42.07–42.10, 47.63–47.65, 72.14–
72.16, 101.95–101.98, 106.13, 106.57, 112.98, 113.42, 113.93–
114.00, 119.50, 124.27–124.49, 126.32–126.36, 128.97–129.06,
130.89–130.91, 132.44–132.56, 132.78, 133.42–133.53, 134.21–
134.57, 140.32–140.41, 148.65–148.68, 152.94–152.96, 157.88–
157.89, 158.54–158.56, 175.37–175.47 ppm. 1H NMR (499.8 MHz,
3
3
CDCl3): δ = 1.46 (d, J = 6.6 Hz, 3 H, Me17), 2.70 (d, J = 1.8 Hz,
3
3 H, MeN2), 3.10 (d, J = 1.8 Hz, 3 H, MeN1), 4.50 (q, 1 H, H17),
6.30 (dd, 1 H, H10), 6.55 (dd, 1 H, H12), 6.88 (t, J = 7.5 Hz, 1 H,
3
H21), 6.96 (d, 3J = 7.8 Hz, 1 H, H19), 7.08 (t, 3J = 7.5 Hz, 1 H,
H20), 7.10–7.20 (m, 2 H, H11, H4), 7.20–7.25 (m, 1 H, H22), 7.30
3
3 H), 2.59 (s, 3 H), 3.03 (d, J = 3.6 Hz, 3 H), 4.20–4.50 (m, 2 H),
3
3
6.60 (m, 2 H), 6.90 (d, J = 8.7 Hz, 3 H), 7.10 (d, J = 8.4 Hz, 3
(m, 1 H, Phm), 7.34 (m, 1 H, Phi), 7.40 (m, 1 H, H6), 7.53 (t, J =
3
H), 7.20–7.80 (m, 13 H), 8.6 (m, 1 H) ppm. [α]2D5 = +107 (c = 0.42,
8.7 Hz, 1 H, H5), 7.66 (m, 2 H, Pho), 7.80 (m, 1 H, H3), ppm
CHCl ). IR (KBr): ν
= 1753 (s) (C=O), 1588 (m), 1453 (m),
˜
3
max
(complex 7a see Figure 3). [α]2D5 = +46.6 (c = 0.42, CHCl3). IR
1435 (s), 1218 cm–1 (s). (HRMS, FAB+): m/z calcd. for
C43H47ClNO4PPd: 813.20, found: 813.1967. C43H47ClNO4PPd
(813.20): calcd. C 63.39, H 5.81; found C 63.42, H 5.93.
(KBr): νmax = 1588 (s), 1541 (m), 1447(s), 1429 (m), 1312 (m), 1218
˜
cm–1 (m). (HRMS, FAB+): m/z calcd. for C28H26NO2PPd: 545.070;
found: 545.074.
Compounds (RP)-9b: Second diastereoisomer eluted (250 mg, 72%).
31P NMR (121.5 MHz, CDCl3): δ = –8.20 ppm. 13C NMR
(126.7 MHz, CDCl3): δ = 16.32, 20.72, 22.24, 23.11, 24.29, 25.83,
31.68, 34.32, 40.96, 46.98, 48.88, 51.79–51.81, 73.45–73.48, 80.38,
108.8, 109.24, 110.93, 111.34, 115.18–115.21, 116.73–116.77,
118.23–118.26, 123.60, 124.24, 124.45–124.50, 124.68–124.79,
125.81, 128.30–128.39, 128.85, 129.12, 130.49–130.50, 131.41,
131.91, 132.78–133.13, 133.35, 136.41, 136.57–136.59, 136.69,
149.82, 150.00–150.02, 152.27–152.34, 153.79–153.81, 154.80 ppm.
1H NMR (300.1 MHz, CDCl3): δ = 0.46 (d, 3J = 6.6 Hz, 3 H),
Compound (SP)-7b: Second diastereoisomer eluted (7 mg, 29%). 31
P
NMR (121.5 MHz, CDCl3):
δ
=
–4.97 ppm. 13C NMR
(126.7 MHz, CDCl3): δ = 25.22, 46.19–46.21, 51.41–51.44, 75.40–
75.43, 101.97–102.00, 106.22, 106.65, 113.17, 113.61, 113.97–
114.03, 119.51–119.54, 123.32, 124.47, 124.57, 125.81–125.85,
128.95–129.04, 130.88–130.90, 132.41–132.52, 132.74–132.75,
133.41–133.53, 134.15–134.51, 140.51–140.85, 145.02–145.06,
156.53–156.55, 157.93–157.95, 158.55–158.57, 175.55–175.65 ppm.
1H NMR (499.8 MHz, CDCl3): δ = 1.70 (d, 3J = 6.3 Hz, 3 H,
3
3
Me17), 2.87 (d, J = 3.3 Hz, 3 H, MeN), 2.92 (d, J = 1.8 Hz, 3 H,
3
0.80–2.00 (m, 15 H), 2.14 (d, J = 6.6 Hz, 3 H), 2.74 (s, 3 H), 2.95
3
(d, J = 3.6 Hz, 3 H), 4.20 (m, 1 H), 4.60 (m, 1 H), 6.70 (m, 2 H),
6.90 (d, 1 H), 7.00–7.80 (m, 14 H), 8.20 (m, 1 H) ppm. [α]2D5 = –85
(c = 0.78, CHCl ). IR (KBr): ν
= 1753 (s) (C=O), 1588 (m),
˜
3
max
1453 (m), 1429 (s), 1218 cm–1 (s). (HRMS, FAB+): m/z calcd. for
C43H47ClNO4PPd: 813.20; found: 813.20. C43H47ClNO4PPd
(813.20): calcd. C 63.39, H 5.81; found C 63.78, H 6.01.
(–)-(1R)-Menthyl (RP)-10-Phenyl-10H-phenoxaphosphan-1-yl Car-
bonate (4a): Compound 9a (30.0 mg) and 1,2-bis(diphenylphos-
phanyl)ethane (14.7 mg) were placed in a Shlenk tube and dis-
solved in dichloromethane (3 mL). The resultant light yellow solu-
tion was stirred for 30min at room temperature and subsequently
the volume of solvent was reduced to about half mL. The solution
Eur. J. Inorg. Chem. 2008, 1309–1317
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjic.org
1315